Clinical Working Party of the European Society of Immunodeficiencies
Octapharma is thrilled to participate in the ESID 2021 online symposium on the immunological consequences of targeted immune therapies #ESID2021. During our sponsored symposium, our speakers discuss about "Secondary Immunodeficiencies in Haematological Malignancies".
This scientific information may include data/information on investigational uses of compounds/drugs that have not yet been approved by regulatory authorities. This program was developed for use outside the U.S., is intended for non-U.S. HCPs, and is to be used in accordance with local laws and regulations.